Lorcaserin - Clinical Trials - Phase III Clinical Trials - BLOOM

BLOOM

BLOOM top line results were released on 30 March 2009. Measurements of efficacy using an intention to treat – last observation carried forward (ITT-LOCF), analysis showed that 47.5% of lorcaserin patients lost at least 5% of their body weight, compared to 20.3% for placebo. This result satisfies one of two alternate efficacy benchmarks in the most recent FDA draft guidance, which provides that a weight-management product can be considered effective if after one year of treatment the proportion of subjects who lose greater than or equal to 5% of baseline body weight in the active-product group is at least 35%, is approximately double the proportion in the placebo-treated group, and the difference between groups is statistically significant.

Additionally, 22.6% of lorcaserin patients lost at least 10% of their body weight, compared to 7.7% for placebo. Lorcaserin patients achieved an average weight loss of 5.8% of their body weight, or 12.7 pounds, compared to 2.2%, or 4.7 pounds, for placebo. Among the most frequent adverse events reported with lorcaserin were headache, dizziness, and nausea.

Read more about this topic:  Lorcaserin, Clinical Trials, Phase III Clinical Trials

Famous quotes containing the word bloom:

    Bees
    Shaking the heavy dews from bloom and frond.
    Boys
    Bursting the surface of the ebony pond.
    Wilfred Owen (1893–1918)

    Loveliest of trees, the cherry now
    Is hung with bloom along the bough,
    And stands about the woodland ride
    Wearing white for Eastertide.
    —A.E. (Alfred Edward)

    Now the hedgerow
    Is blanched for an hour with transitory blossom
    Of snow, a bloom more sudden
    Than that of summer,
    —T.S. (Thomas Stearns)